Posted by: SomaNews on: 10 Oct, 2009
‘Red Wine’ Chemical May One Day Treat Diabetes The much touted red wine compound resveratrol shows some promise as a future treatment for type 2 diabetes, but drinking wine or taking resveratrol supplements isn’t likely to do diabetic people much good, researchers say.
Posted by: SomaNews on: 10 Oct, 2009
Swine Flu Cases Rise; CDC Urges Vaccination As the number of H1N1 swine flu cases continues to rise in the U.S., officials from the CDC urge the public to consider getting vaccinated against both swine flu and seasonal flu.
Posted by: SomaNews on: 10 Oct, 2009
Cancer Signs in Teens Often Overlooked In the first study of its kind, British researchers have found that teen and young adult cancer patients often feel frustrated that their symptoms are not taken seriously.
Posted by: SomaNews on: 10 Oct, 2009
Controlled trial comparing Bevacizumab to Ranibizumab finds no difference in efficacy Investigators from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have shown, at 6 months in a small group of patients, that there is no difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular [...]
Posted by: SomaNews on: 10 Oct, 2009
State governments start swine flu vaccine campaign Questions, answers and reactions emerge as various states and counties distribute H1N1 flu vaccines.
Posted by: SomaNews on: 10 Oct, 2009
Cox’s initiative to safegaurd the community at-large Recognized as a leader in serving its customers with state-of-the-art cable, broadband and entertainment services, Cox will soon broaden its local impact by safeguarding the community at-large. On October 30, 2009, Cox will be the first and only private corporation to operate as one of three Orange County [...]
Posted by: SomaNews on: 10 Oct, 2009
Report on the European and U.S. market for omega-3 Research and Markets (http://www.researchandmarkets.com/research/bc9ff2/omega3_fad_or_f) has announced the addition of the “Omega-3 – Fad or Future? European and US Combo Reports” report to their offering.
Posted by: SomaNews on: 10 Oct, 2009
Fresenius provides VitalProteinRx for protein replacement in patients with chronic kidney disease VitalRemedyMD, a physician-established company, offers scientifically formulated integrative nutritional supplements designed to improve the quality of traditional healthcare. “We are proud that VitalProteinRx is now an integral part of Fresenius’ armamentarium in helping patients with chronic kidney disease,” stated Dr. Seth Baum, Founder [...]
Posted by: SomaNews on: 10 Oct, 2009
CREON Delayed-Release Capsules improves fat absorption in patients with Cystic Fibrosis Solvay Pharmaceuticals, Inc. announced today that Phase III data published in the Journal of Cystic Fibrosis showed that CREON® (pancrelipase) Delayed-Release Capsules, the most prescribed pancreatic enzyme replacement therapy (PERT) in the United States, significantly improves a key measure of fat absorption in patients [...]
Posted by: SomaNews on: 10 Oct, 2009
Spectrum Pharmaceuticals receives FDA Complete Response letter for FUSILEV Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding its supplemental New Drug Application (sNDA) for FUSILEV® (levoleucovorin) for injection for treatment of patients with [...]
Recent Comments